Balance Sheets (Unaudited) - USD ($)	Dec. 31, 2015	Dec. 31, 2014
Current assets
Cash and cash equivalents	$ 2,173,258	$ 2,538,758
Short term investments	1,651,341	7,399,636
Accounts receivable, trade, net of allowance for doubtful accounts of $0 at December 31, 2015 and 2014	929,289	901,623
Inventories	1,834,635	965,224
Prepaid expenses and other current assets	384,414	360,521
Total current assets	6,972,937	12,165,762
Property and equipment
Leasehold improvements	1,284,491	1,284,491
Furniture and computer equipment	557,666	476,788
Manufacturing and other equipment	1,025,521	972,386
Subtotal	2,867,678	2,733,665
Less: Accumulated depreciation	(1,421,279)	(1,078,060)
Net property and equipment	1,446,399	1,655,605
Internal use software	1,698,735	0
Intangible asset	2,215,385	2,215,385
Long term deposits	36,166	36,166
Total assets	12,369,622	16,072,918
Current liabilities
Accounts payable	1,029,373	474,662
Accrued expenses and other current liabilities	146,438	121,869
Accrued compensation	419,766	535,029
Deferred rent, current portion	130,216	130,216
Total current liabilities	1,725,793	1,261,776
Long term liabilities
Deferred rent, long term	784,458	874,825
Total liabilities	2,510,251	$ 2,136,601
Commitments and Contingencies (Note 10)
Shareholders' equity
Common stock, $0.001 par value; 150,000,000 shares authorized, 12,448,391 and 12,084,859 shares issued and outstanding at December 31, 2015 and 2014	12,447	$ 12,084
Additional paid-in capital	72,823,398	71,911,328
Accumulated other comprehensive loss	(451)	(6,448)
Accumulated deficit	(64,326,923)	(60,112,987)
Total BioLife Solutions, Inc. shareholders' equity	8,508,471	11,803,977
Total non-controlling interest equity	1,350,900	2,132,340
Total shareholders' equity	9,859,371	13,936,317
Total liabilities and shareholders' equity	$ 12,369,622	$ 16,072,918